Order Article Reprints

Baudry G, Pozzi M, Aubry M, Hugon-Vallet E, Mocan R, Chalabreysse L, Portran P, Obadia J-F, Thaunat O, Girerd N, et al. De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival. Journal of Clinical Medicine. 2022; 11(13):3731. https://doi.org/10.3390/jcm11133731

Baudry, Guillaume, Matteo Pozzi, Matthieu Aubry, Elisabeth Hugon-Vallet, Raluca Mocan, Lara Chalabreysse, Philippe Portran, Jean-François Obadia, Olivier Thaunat, Nicolas Girerd, and et al. 2022. "De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival" Journal of Clinical Medicine 11, no. 13: 3731. https://doi.org/10.3390/jcm11133731

Baudry, G., Pozzi, M., Aubry, M., Hugon-Vallet, E., Mocan, R., Chalabreysse, L., Portran, P., Obadia, J.-F., Thaunat, O., Girerd, N., Dubois, V., & Sebbag, L. (2022). De Novo Complement-Binding Anti-HLA Antibodies in Heart Transplanted Patients Is Associated with Severe Cardiac Allograft Vasculopathy and Poor Long-Term Survival. Journal of Clinical Medicine, 11(13), 3731. https://doi.org/10.3390/jcm11133731